APO Research

APO RESEARCH · REPORT

Medicated Confectionery

Selected research

Market Structure

Global Medicated Confectionery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Medicated Confectionery market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medicated Confectionery include Perfetti Van Melle (Halls), Reckitt Benckiser (Strepsils), Ricola AG, Jakemans, Wrigley Company, Mondelez International (Ernest Jackson), Nestle, Procter & Gamble and Meda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medicated Confectionery market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medicated Confectionery and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medicated Confectionery sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medicated Confectionery market size, projected growth trends, production technologies, key applications, and end-use industries.

Medicated Confectionery Segment by Company

Perfetti Van Melle (Halls)

Reckitt Benckiser (Strepsils)

Ricola AG

Jakemans

Wrigley Company

Mondelez International (Ernest Jackson)

Nestle

Procter & Gamble

Meda Pharmaceuticals

UHA Mikakuto

Herbion International

HEXOS

Lofthouse of Fleetwood

Läkerol

Luden's

Olbas

Baker Perkins Limited

Medicated Confectionery Segment by Type

Lozenges

Chewable Tablets

Gummy

Other

Medicated Confectionery Segment by Application

Pharmacies/Drugstores

Supermarkets/Convenience Stores

Health & Wellness Stores

Hospital/Clinic Pharmacies

Online Retailers

Medicated Confectionery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicated Confectionery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medicated Confectionery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicated Confectionery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medicated Confectionery market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medicated Confectionery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Medicated Confectionery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Medicated Confectionery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Medicated Confectionery Industry Trends Table 2. Medicated Confectionery Industry Drivers Table 3. Medicated Confectionery Industry Opportunities and Challenges Table 4. Medicated Confectionery Industry Restraints Table 5. Global Medicated Confectionery Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Medicated Confectionery Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Medicated Confectionery Sales by Manufacturers (kt) & (2021-2026) Table 8. Global Medicated Confectionery Sales Market Share by Manufacturers Table 9. Global Medicated Confectionery Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Medicated Confectionery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Medicated Confectionery Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Medicated Confectionery Manufacturers, Product Type & Application Table 13. Global Medicated Confectionery Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Medicated Confectionery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lozenges Table 17. Major Manufacturers of Chewable Tablets Table 18. Major Manufacturers of Gummy Table 19. Major Manufacturers of Other Table 20. Global Medicated Confectionery Sales by Type 2021 VS 2025 VS 2032 (kt) Table 21. Global Medicated Confectionery Sales by Type (2021-2026) & (kt) Table 22. Global Medicated Confectionery Sales by Type (2027-2032) & (kt) Table 23. Global Medicated Confectionery Sales Market Share by Type (2021-2026) Table 24. Global Medicated Confectionery Sales Market Share by Type (2027-2032) Table 25. Global Medicated Confectionery Revenue by Type 2021 VS 2025 VS 2032 (kt) Table 26. Global Medicated Confectionery Revenue by Type (2021-2026) & (kt) Table 27. Global Medicated Confectionery Revenue by Type (2027-2032) & (kt) Table 28. Global Medicated Confectionery Revenue Market Share by Type (2021-2026) Table 29. Global Medicated Confectionery Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmacies/Drugstores Table 31. Major Manufacturers of Supermarkets/Convenience Stores Table 32. Major Manufacturers of Health & Wellness Stores Table 33. Major Manufacturers of Hospital/Clinic Pharmacies Table 34. Major Manufacturers of Online Retailers Table 35. Global Medicated Confectionery Sales by Application 2021 VS 2025 VS 2032 (kt) Table 36. Global Medicated Confectionery Sales by Application (2021-2026) & (kt) Table 37. Global Medicated Confectionery Sales by Application (2027-2032) & (kt) Table 38. Global Medicated Confectionery Sales Market Share by Application (2021-2026) Table 39. Global Medicated Confectionery Sales Market Share by Application (2027-2032) Table 40. Global Medicated Confectionery Revenue by Application 2021 VS 2025 VS 2032 (kt) Table 41. Global Medicated Confectionery Revenue by Application (2021-2026) & (kt) Table 42. Global Medicated Confectionery Revenue by Application (2027-2032) & (kt) Table 43. Global Medicated Confectionery Revenue Market Share by Application (2021-2026) Table 44. Global Medicated Confectionery Revenue Market Share by Application (2027-2032) Table 45. Global Medicated Confectionery Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 46. Global Medicated Confectionery Sales by Region (2021-2026) & (kt) Table 47. Global Medicated Confectionery Sales Market Share by Region (2021-2026) Table 48. Global Medicated Confectionery Sales Forecasted by Region (2027-2032) & (kt) Table 49. Global Medicated Confectionery Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 51. North America Medicated Confectionery Sales by Country (2021-2026) & (kt) Table 52. North America Medicated Confectionery Sales by Country (2027-2032) & (kt) Table 53. Europe Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 54. Europe Medicated Confectionery Sales by Country (2021-2026) & (kt) Table 55. Europe Medicated Confectionery Sales by Country (2027-2032) & (kt) Table 56. Asia Pacific Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 57. Asia Pacific Medicated Confectionery Sales by Country (2021-2026) & (kt) Table 58. Asia Pacific Medicated Confectionery Sales by Country (2027-2032) & (kt) Table 59. South America, Middle East and Africa Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 60. South America, Middle East and Africa Medicated Confectionery Sales by Country (2021-2026) & (kt) Table 61. South America, Middle East and Africa Medicated Confectionery Sales by Country (2027-2032) & (kt) Table 62. Global Medicated Confectionery Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Medicated Confectionery Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Medicated Confectionery Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Medicated Confectionery Revenue Market Share by Region (2021-2026) Table 66. Global Medicated Confectionery Revenue Market Share by Region (2027-2032) Table 67. Perfetti Van Melle (Halls) Company Information Table 68. Perfetti Van Melle (Halls) Business Overview Table 69. Perfetti Van Melle (Halls) Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Perfetti Van Melle (Halls) Medicated Confectionery Product Portfolio Table 71. Perfetti Van Melle (Halls) Recent Development Table 72. Reckitt Benckiser (Strepsils) Company Information Table 73. Reckitt Benckiser (Strepsils) Business Overview Table 74. Reckitt Benckiser (Strepsils) Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Reckitt Benckiser (Strepsils) Medicated Confectionery Product Portfolio Table 76. Reckitt Benckiser (Strepsils) Recent Development Table 77. Ricola AG Company Information Table 78. Ricola AG Business Overview Table 79. Ricola AG Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Ricola AG Medicated Confectionery Product Portfolio Table 81. Ricola AG Recent Development Table 82. Jakemans Company Information Table 83. Jakemans Business Overview Table 84. Jakemans Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Jakemans Medicated Confectionery Product Portfolio Table 86. Jakemans Recent Development Table 87. Wrigley Company Company Information Table 88. Wrigley Company Business Overview Table 89. Wrigley Company Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Wrigley Company Medicated Confectionery Product Portfolio Table 91. Wrigley Company Recent Development Table 92. Mondelez International (Ernest Jackson) Company Information Table 93. Mondelez International (Ernest Jackson) Business Overview Table 94. Mondelez International (Ernest Jackson) Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Mondelez International (Ernest Jackson) Medicated Confectionery Product Portfolio Table 96. Mondelez International (Ernest Jackson) Recent Development Table 97. Nestle Company Information Table 98. Nestle Business Overview Table 99. Nestle Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Nestle Medicated Confectionery Product Portfolio Table 101. Nestle Recent Development Table 102. Procter & Gamble Company Information Table 103. Procter & Gamble Business Overview Table 104. Procter & Gamble Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Procter & Gamble Medicated Confectionery Product Portfolio Table 106. Procter & Gamble Recent Development Table 107. Meda Pharmaceuticals Company Information Table 108. Meda Pharmaceuticals Business Overview Table 109. Meda Pharmaceuticals Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Meda Pharmaceuticals Medicated Confectionery Product Portfolio Table 111. Meda Pharmaceuticals Recent Development Table 112. UHA Mikakuto Company Information Table 113. UHA Mikakuto Business Overview Table 114. UHA Mikakuto Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. UHA Mikakuto Medicated Confectionery Product Portfolio Table 116. UHA Mikakuto Recent Development Table 117. Herbion International Company Information Table 118. Herbion International Business Overview Table 119. Herbion International Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Herbion International Medicated Confectionery Product Portfolio Table 121. Herbion International Recent Development Table 122. HEXOS Company Information Table 123. HEXOS Business Overview Table 124. HEXOS Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. HEXOS Medicated Confectionery Product Portfolio Table 126. HEXOS Recent Development Table 127. Lofthouse of Fleetwood Company Information Table 128. Lofthouse of Fleetwood Business Overview Table 129. Lofthouse of Fleetwood Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Lofthouse of Fleetwood Medicated Confectionery Product Portfolio Table 131. Lofthouse of Fleetwood Recent Development Table 132. Läkerol Company Information Table 133. Läkerol Business Overview Table 134. Läkerol Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Läkerol Medicated Confectionery Product Portfolio Table 136. Läkerol Recent Development Table 137. Luden's Company Information Table 138. Luden's Business Overview Table 139. Luden's Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Luden's Medicated Confectionery Product Portfolio Table 141. Luden's Recent Development Table 142. Olbas Company Information Table 143. Olbas Business Overview Table 144. Olbas Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Olbas Medicated Confectionery Product Portfolio Table 146. Olbas Recent Development Table 147. Baker Perkins Limited Company Information Table 148. Baker Perkins Limited Business Overview Table 149. Baker Perkins Limited Medicated Confectionery Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Baker Perkins Limited Medicated Confectionery Product Portfolio Table 151. Baker Perkins Limited Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Medicated Confectionery Distributors List Table 155. Medicated Confectionery Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Medicated Confectionery Product Image Figure 2. Global Medicated Confectionery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medicated Confectionery Market Size (2021-2032) & (US$ Million) Figure 4. Global Medicated Confectionery Sales (2021-2032) & (kt) Figure 5. Global Medicated Confectionery Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Medicated Confectionery Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lozenges Image Figure 9. Chewable Tablets Image Figure 10. Gummy Image Figure 11. Other Image Figure 12. Global Medicated Confectionery Sales by Type (2021 VS 2025 VS 2032) & (kt) Figure 13. Global Medicated Confectionery Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Medicated Confectionery Sales Market Share by Type (2021-2032) Figure 15. Global Medicated Confectionery Revenue by Type (2021 VS 2025 VS 2032) & (kt) Figure 16. Global Medicated Confectionery Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Medicated Confectionery Revenue Market Share by Type (2021-2032) Figure 18. Pharmacies/Drugstores Image Figure 19. Supermarkets/Convenience Stores Image Figure 20. Health & Wellness Stores Image Figure 21. Hospital/Clinic Pharmacies Image Figure 22. Online Retailers Image Figure 23. Global Medicated Confectionery Sales by Application (2021 VS 2025 VS 2032) & (kt) Figure 24. Global Medicated Confectionery Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Medicated Confectionery Sales Market Share by Application (2021-2032) Figure 26. Global Medicated Confectionery Revenue by Application (2021 VS 2025 VS 2032) & (kt) Figure 27. Global Medicated Confectionery Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Medicated Confectionery Revenue Market Share by Application (2021-2032) Figure 29. North America Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 30. North America Medicated Confectionery Sales Market Share by Country (2021-2032) Figure 31. U.S. Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 32. Canada Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 33. Mexico Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 34. Europe Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 35. Europe Medicated Confectionery Sales Market Share by Country (2021-2032) Figure 36. Germany Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 37. France Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 38. U.K. Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 39. Italy Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 40. Netherlands Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 41. Asia Pacific Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 42. Asia Pacific Medicated Confectionery Sales Market Share by Country (2021-2032) Figure 43. China Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 44. Japan Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 45. South Korea Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 46. Southeast Asia Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 47. India Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 48. Australia Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 49. South America, Middle East and Africa Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 50. South America, Middle East and Africa Medicated Confectionery Sales Market Share by Country (2021-2032) Figure 51. Brazil Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 52. South Africa Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 53. Saudi Arabia Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 54. Turkey Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 55. Argentina Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 56. UAE Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 57. Egypt Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 58. Chile Medicated Confectionery Sales and Growth Rate (2021-2032) & (kt) Figure 59. Global Medicated Confectionery Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Medicated Confectionery Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Medicated Confectionery Revenue (2021-2032) & (US$ Million) Figure 62. North America Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Medicated Confectionery Revenue (2021-2032) & (US$ Million) Figure 64. Europe Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Medicated Confectionery Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Medicated Confectionery Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Medicated Confectionery Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Medicated Confectionery Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Lozenges
  • Chewable Tablets
  • Gummy
  • Other
Applications
  • Pharmacies/Drugstores
  • Supermarkets/Convenience Stores
  • Health & Wellness Stores
  • Hospital/Clinic Pharmacies
  • Online Retailers
Companies covered
  • Perfetti Van Melle (Halls)
  • Reckitt Benckiser (Strepsils)
  • Ricola AG
  • Jakemans
  • Wrigley Company
  • Mondelez International (Ernest Jackson)
  • Nestle
  • Procter & Gamble
  • Meda Pharmaceuticals
  • UHA Mikakuto
  • Herbion International
  • HEXOS
  • Lofthouse of Fleetwood
  • Läkerol
  • Luden's
  • Olbas
  • Baker Perkins Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medicated Confectionery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medicated Confectionery Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Medicated Confectionery Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Medicated Confectionery Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Medicated Confectionery Market Dynamics
  1. 2.1 Medicated Confectionery Industry Trends
  2. 2.2 Medicated Confectionery Industry Drivers
  3. 2.3 Medicated Confectionery Industry Opportunities and Challenges
  4. 2.4 Medicated Confectionery Industry Restraints
3 Medicated Confectionery Market by Manufacturers
  1. 3.1 Global Medicated Confectionery Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Medicated Confectionery Sales by Manufacturers (2021-2026)
  3. 3.3 Global Medicated Confectionery Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Medicated Confectionery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medicated Confectionery Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Medicated Confectionery Manufacturers, Product Type & Application
  7. 3.7 Global Medicated Confectionery Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medicated Confectionery Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medicated Confectionery Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medicated Confectionery Tier 1, Tier 2, and Tier 3
4 Medicated Confectionery Market by Type
  1. 4.1 Medicated Confectionery Type Introduction
  2. 4.1.1 Lozenges
  3. 4.1.2 Chewable Tablets
  4. 4.1.3 Gummy
  5. 4.1.4 Other
  6. 4.2 Global Medicated Confectionery Sales by Type
  7. 4.2.1 Global Medicated Confectionery Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medicated Confectionery Sales by Type (2021-2032)
  9. 4.2.3 Global Medicated Confectionery Sales Market Share by Type (2021-2032)
  10. 4.3 Global Medicated Confectionery Revenue by Type
  11. 4.3.1 Global Medicated Confectionery Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Medicated Confectionery Revenue by Type (2021-2032)
  13. 4.3.3 Global Medicated Confectionery Revenue Market Share by Type (2021-2032)
5 Medicated Confectionery Market by Application
  1. 5.1 Medicated Confectionery Application Introduction
  2. 5.1.1 Pharmacies/Drugstores
  3. 5.1.2 Supermarkets/Convenience Stores
  4. 5.1.3 Health & Wellness Stores
  5. 5.1.4 Hospital/Clinic Pharmacies
  6. 5.1.5 Online Retailers
  7. 5.2 Global Medicated Confectionery Sales by Application
  8. 5.2.1 Global Medicated Confectionery Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Medicated Confectionery Sales by Application (2021-2032)
  10. 5.2.3 Global Medicated Confectionery Sales Market Share by Application (2021-2032)
  11. 5.3 Global Medicated Confectionery Revenue by Application
  12. 5.3.1 Global Medicated Confectionery Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Medicated Confectionery Revenue by Application (2021-2032)
  14. 5.3.3 Global Medicated Confectionery Revenue Market Share by Application (2021-2032)
6 Global Medicated Confectionery Sales by Region
  1. 6.1 Global Medicated Confectionery Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medicated Confectionery Sales by Region (2021-2032)
  3. 6.2.1 Global Medicated Confectionery Sales by Region (2021-2026)
  4. 6.2.2 Global Medicated Confectionery Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Medicated Confectionery Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Medicated Confectionery Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Medicated Confectionery Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Medicated Confectionery Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Medicated Confectionery Revenue by Region
  1. 7.1 Global Medicated Confectionery Revenue by Region
  2. 7.1.1 Global Medicated Confectionery Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Medicated Confectionery Revenue by Region (2021-2026)
  4. 7.1.3 Global Medicated Confectionery Revenue by Region (2027-2032)
  5. 7.1.4 Global Medicated Confectionery Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Medicated Confectionery Revenue (2021-2032)
  8. 7.2.2 North America Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Medicated Confectionery Revenue (2021-2032)
  11. 7.3.2 Europe Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Medicated Confectionery Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Medicated Confectionery Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Perfetti Van Melle (Halls)
  2. 8.1.1 Perfetti Van Melle (Halls) Company Information
  3. 8.1.2 Perfetti Van Melle (Halls) Business Overview
  4. 8.1.3 Perfetti Van Melle (Halls) Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Perfetti Van Melle (Halls) Medicated Confectionery Product Portfolio
  6. 8.1.5 Perfetti Van Melle (Halls) Recent Developments
  7. 8.2 Reckitt Benckiser (Strepsils)
  8. 8.2.1 Reckitt Benckiser (Strepsils) Company Information
  9. 8.2.2 Reckitt Benckiser (Strepsils) Business Overview
  10. 8.2.3 Reckitt Benckiser (Strepsils) Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Reckitt Benckiser (Strepsils) Medicated Confectionery Product Portfolio
  12. 8.2.5 Reckitt Benckiser (Strepsils) Recent Developments
  13. 8.3 Ricola AG
  14. 8.3.1 Ricola AG Company Information
  15. 8.3.2 Ricola AG Business Overview
  16. 8.3.3 Ricola AG Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ricola AG Medicated Confectionery Product Portfolio
  18. 8.3.5 Ricola AG Recent Developments
  19. 8.4 Jakemans
  20. 8.4.1 Jakemans Company Information
  21. 8.4.2 Jakemans Business Overview
  22. 8.4.3 Jakemans Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jakemans Medicated Confectionery Product Portfolio
  24. 8.4.5 Jakemans Recent Developments
  25. 8.5 Wrigley Company
  26. 8.5.1 Wrigley Company Company Information
  27. 8.5.2 Wrigley Company Business Overview
  28. 8.5.3 Wrigley Company Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wrigley Company Medicated Confectionery Product Portfolio
  30. 8.5.5 Wrigley Company Recent Developments
  31. 8.6 Mondelez International (Ernest Jackson)
  32. 8.6.1 Mondelez International (Ernest Jackson) Company Information
  33. 8.6.2 Mondelez International (Ernest Jackson) Business Overview
  34. 8.6.3 Mondelez International (Ernest Jackson) Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mondelez International (Ernest Jackson) Medicated Confectionery Product Portfolio
  36. 8.6.5 Mondelez International (Ernest Jackson) Recent Developments
  37. 8.7 Nestle
  38. 8.7.1 Nestle Company Information
  39. 8.7.2 Nestle Business Overview
  40. 8.7.3 Nestle Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nestle Medicated Confectionery Product Portfolio
  42. 8.7.5 Nestle Recent Developments
  43. 8.8 Procter & Gamble
  44. 8.8.1 Procter & Gamble Company Information
  45. 8.8.2 Procter & Gamble Business Overview
  46. 8.8.3 Procter & Gamble Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Procter & Gamble Medicated Confectionery Product Portfolio
  48. 8.8.5 Procter & Gamble Recent Developments
  49. 8.9 Meda Pharmaceuticals
  50. 8.9.1 Meda Pharmaceuticals Company Information
  51. 8.9.2 Meda Pharmaceuticals Business Overview
  52. 8.9.3 Meda Pharmaceuticals Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Meda Pharmaceuticals Medicated Confectionery Product Portfolio
  54. 8.9.5 Meda Pharmaceuticals Recent Developments
  55. 8.10 UHA Mikakuto
  56. 8.10.1 UHA Mikakuto Company Information
  57. 8.10.2 UHA Mikakuto Business Overview
  58. 8.10.3 UHA Mikakuto Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 UHA Mikakuto Medicated Confectionery Product Portfolio
  60. 8.10.5 UHA Mikakuto Recent Developments
  61. 8.11 Herbion International
  62. 8.11.1 Herbion International Company Information
  63. 8.11.2 Herbion International Business Overview
  64. 8.11.3 Herbion International Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Herbion International Medicated Confectionery Product Portfolio
  66. 8.11.5 Herbion International Recent Developments
  67. 8.12 HEXOS
  68. 8.12.1 HEXOS Company Information
  69. 8.12.2 HEXOS Business Overview
  70. 8.12.3 HEXOS Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HEXOS Medicated Confectionery Product Portfolio
  72. 8.12.5 HEXOS Recent Developments
  73. 8.13 Lofthouse of Fleetwood
  74. 8.13.1 Lofthouse of Fleetwood Company Information
  75. 8.13.2 Lofthouse of Fleetwood Business Overview
  76. 8.13.3 Lofthouse of Fleetwood Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Lofthouse of Fleetwood Medicated Confectionery Product Portfolio
  78. 8.13.5 Lofthouse of Fleetwood Recent Developments
  79. 8.14 Läkerol
  80. 8.14.1 Läkerol Company Information
  81. 8.14.2 Läkerol Business Overview
  82. 8.14.3 Läkerol Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Läkerol Medicated Confectionery Product Portfolio
  84. 8.14.5 Läkerol Recent Developments
  85. 8.15 Luden's
  86. 8.15.1 Luden's Company Information
  87. 8.15.2 Luden's Business Overview
  88. 8.15.3 Luden's Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Luden's Medicated Confectionery Product Portfolio
  90. 8.15.5 Luden's Recent Developments
  91. 8.16 Olbas
  92. 8.16.1 Olbas Company Information
  93. 8.16.2 Olbas Business Overview
  94. 8.16.3 Olbas Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Olbas Medicated Confectionery Product Portfolio
  96. 8.16.5 Olbas Recent Developments
  97. 8.17 Baker Perkins Limited
  98. 8.17.1 Baker Perkins Limited Company Information
  99. 8.17.2 Baker Perkins Limited Business Overview
  100. 8.17.3 Baker Perkins Limited Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Baker Perkins Limited Medicated Confectionery Product Portfolio
  102. 8.17.5 Baker Perkins Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medicated Confectionery Value Chain Analysis
  2. 9.1.1 Medicated Confectionery Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medicated Confectionery Production Mode & Process
  6. 9.2 Medicated Confectionery Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medicated Confectionery Distributors
  9. 9.2.3 Medicated Confectionery Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research